참고문헌
- Bhurgri Y, Bhurgri A, Nishter S, et al (2006). Pakistan-country profile of cancer and cancer control 1995-2004. J Pak Med Assoc, 56, 124-30.
- Bhurgri Y, Kayani N, Faridi N, et al (2007). Patho-epidemiology of breast cancer in Karachi "1995-1997". Asian Pac J Cancer Prev, 8, 215-20.
- Carlson GW, Wood WC (2011). Management of axillary lymph node metastasis in breast cancer: making progress. JAMA, 305, 606. https://doi.org/10.1001/jama.2011.131
- Chagpar A, Middleton LP, Sahin AA, et al (2005). Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer, 103, 1581-6. https://doi.org/10.1002/cncr.20934
- Chen SL, Hoehne FM, Giuliano AE (2007). The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol, 14, 3378-84. https://doi.org/10.1245/s10434-007-9513-6
- Cody HS III, Borgen PI (1999). State-of-the-art approaches to sentinel node biopsy for breast cancer: study design, patient selection, technique, and quality control at Memorial Sloan-Kettering Cancer Center. Surg Oncol, 8, 85-91. https://doi.org/10.1016/S0960-7404(99)00029-8
- Cox CE, Kiluk JV, Riker AI, et al (2008). Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg, 206, 261-8. https://doi.org/10.1016/j.jamcollsurg.2007.08.024
- Dowlatshahi K, Fan M, Bloom KJ, et al (1999). Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer, 86, 990-6. https://doi.org/10.1002/(SICI)1097-0142(19990915)86:6<990::AID-CNCR14>3.0.CO;2-D
- Edge SB, Compton CC (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol, 17, 1471-4. https://doi.org/10.1245/s10434-010-0985-4
- Fan YG, Tan YY, Wu CT, et al (2005). The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer. Ann Surg Oncol, 12, 705-11. https://doi.org/10.1245/ASO.2005.08.020
- Fisher B, Bauer M, Wickerham DL, et al (1983). Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer, 52, 1551-7. https://doi.org/10.1002/1097-0142(19831101)52:9<1551::AID-CNCR2820520902>3.0.CO;2-3
- Galimberti V, Cole BF, Zurrida S, et al [S3-1] Update of International Breast Cancer Study Group Trial 23-01 To Compare Axillary Dissection Versus No Axillary Dissection in Patients with Clinically Node Negative Breast Cancer and Micrometastases in the Sentinel Node. http://www. abstracts2view.com/sabcs11/view.php?nu=SABCS11L_150
- Giuliano AE, Hunt KK, Ballman KV, et al (2011). Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA, 305, 569. https://doi.org/10.1001/jama.2011.90
- Giuliano AE, Kirgan DM, Guenther JM, et al (1994). Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 220, 391-401. https://doi.org/10.1097/00000658-199409000-00015
- Giuliano AE, Kirgan DM, Guenther JM (1994) Morton DL: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg, 220, 391-8. https://doi.org/10.1097/00000658-199409000-00015
- Giuliano AE, McCall L, Beitsch P, et al (2010). Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg, 252, 426.
- Gobardhan PD, Elias SG, Madsen EV, et al (2009). Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study. Ann Oncol, 20, 41-8.
- Imoto S, Ochiai A, Okumura C, Wada N, Hasebe T (2006). Impact of isolated tumor cells in sentinel lymph nodes detected by immunohistochemical staining. Eur J Surg Oncol, 32, 1175-9. https://doi.org/10.1016/j.ejso.2006.08.006
- Krag D, Weaver D, Ashikaga T, et al (1998). Beitsch P: The sentinel node in breast cancer-a multicenter validation study. N Engl J Med, 339, 941-6. https://doi.org/10.1056/NEJM199810013391401
- Layfield DM, Arawal A, Roche H, Cuttress RI (2011). Intraoperative assessment of sentinel lymph nodes in breast cancer. Br J Surg, 98, 4-17 https://doi.org/10.1002/bjs.7229
- Liang WC, Sickle-Santanello BJ, Nims TA (2001). Is a completion axillary dissection indicated for micrometastases in the sentinel lymph node. Am J Surg, 182, 365-8. https://doi.org/10.1016/S0002-9610(01)00738-3
- Nagashima T, Sakakibara M, Nakano S, et al (2006). Sentinel node micrometastasis and distant failure in breast cancer patients. Breast Cancer, 13, 186-91. https://doi.org/10.2325/jbcs.13.186
- O'Hea BJ, Hill AD, El-Shirbiny AM, et al (1998). Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg, 186, 423-7. https://doi.org/10.1016/S1072-7515(98)00060-X
- Ryden L, Chebil G, Sjostrom L, Pawlowski R, Jonsson PE (2007). Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy. Eur J Surg Oncol, 33, 33-8. https://doi.org/10.1016/j.ejso.2006.11.007
- Sanuki N, Takeda A, Amemiya A, et al (2013). Outcomes of clinically node-negative breast cancer without axillary dissection: can preserved axilla be safely treated with radiation after a positive sentinel node biopsy? Clin Breast Cancer, 13, 69. https://doi.org/10.1016/j.clbc.2012.09.005
- Soni NK, Spillane AJ (2005). Experience of sentinel node biopsy alone in early breast cancer without further axillary dissection in patients with negative sentinel node. ANZ J Surg, 75, 292-9. https://doi.org/10.1111/j.1445-2197.2005.03376.x
- Tille JC, Egger JF, Devillaz MC, Vlastos G, Pelte MF (2009). Frozen section in axillary sentinel lymph nodes for diagnosis of breast cancer micrometastasis. Anticancer Res, 29, 4711-6.
- Turner RR, Ollila DW, Stern S, Giuliano AE (1999). Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol, 23, 263-7. https://doi.org/10.1097/00000478-199903000-00003
- Veronesi U, Paganelli G, Galimberti V, et al (1997). Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet, 349, 1864-7. https://doi.org/10.1016/S0140-6736(97)01004-0
- Veronesi U, Paganelli G, Viale G, et al (1999). Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst, 91, 368-73. https://doi.org/10.1093/jnci/91.4.368
- Viale G, Bosari S, Mazzarol G, et al (1999). Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients. Cancer, 85, 2433-8. https://doi.org/10.1002/(SICI)1097-0142(19990601)85:11<2433::AID-CNCR18>3.0.CO;2-3
- Weaver DL, Krag DN, Ashikaga T, Harlow SP (2000). O'Connell M: Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer, 88, 1099-107. https://doi.org/10.1002/(SICI)1097-0142(20000301)88:5<1099::AID-CNCR22>3.0.CO;2-7
피인용 문헌
- Diagnostic accuracy of touch imprint cytology for head and neck malignancies: a useful intra-operative tool in resource limited countries vol.17, pp.1, 2017, https://doi.org/10.1186/s12907-017-0063-y
- Prognostic parameters of luminal A and luminal B intrinsic breast cancer subtypes of Pakistani patients vol.16, pp.1, 2018, https://doi.org/10.1186/s12957-017-1299-9
- Prognostic significance of p16 & p53 immunohistochemical expression in triple negative breast cancer vol.18, pp.1, 2018, https://doi.org/10.1186/s12907-018-0077-0
- Cytokeratin 5/6 and cytokeratin 8/18 expression in triple negative breast cancers: clinicopathologic significance in South-Asian population vol.11, pp.1, 2018, https://doi.org/10.1186/s13104-018-3477-4